欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号SE/H/1866/002
药品名称octaplasLG
活性成分
    • human plasma proteins 0.0 mg/ml
剂型Powder and solvent for solution for infusion
上市许可持有人Octapharma AB
参考成员国 - 产品名称Sweden (SE)
互认成员国 - 产品名称
    • Austria (AT)
      Octaplas LG 45 - 70 mg/ml Infusionslösung
    • France (FR)
    • Spain (ES)
    • Norway (NO)
    • Finland (FI)
      OctaplasLG Lyo
    • Hungary (HU)
      OCTAPLASLG 45-70 mg/ml oldatos infúzió
    • Bulgaria (BG)
    • Denmark (DK)
    • Czechia (CZ)
      octaplas LG LYO
    • Belgium (BE)
    • Malta (MT)
      octaplasLG Lyo, powder and solvent for solution for infusion
    • Netherlands (NL)
      Omniplasma Lyo
    • Croatia (HR)
    • Luxembourg (LU)
    • Ireland (IE)
许可日期2023/02/01
最近更新日期2025/09/23
药物ATC编码
    • B05AA Blood substitutes and plasma protein fractions
申请类型
  • TypeLevel1：Line Extension
  • TypeLevel2：Additional Strength/Form
  • TypeLevel3：Full Dossier Art 8.3(i) Dir 2001/83/EC
  • TypeLevel4：Biological: Blood Product
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase